WOOJUNG BIO Inc (215380) — Cash Flow-to-Debt Ratio
WOOJUNG BIO Inc (215380) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of ₩-1.51 Billion could theoretically repay 0% of its total liabilities (₩98.45 Billion) in one year. See WOOJUNG BIO Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
WOOJUNG BIO Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for WOOJUNG BIO Inc across 10 annual periods. For the full cash flow conversion analysis, see 215380 cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for WOOJUNG BIO Inc (2016–2025)
Year-by-year debt coverage analysis for WOOJUNG BIO Inc. Check WOOJUNG BIO Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | ₩-630.50 Million | ₩63.42 Billion | ▲ +42.3% |
| 2024 | -0.02x | ₩-1.13 Billion | ₩65.33 Billion | ▲ +59.1% |
| 2023 | -0.04x | ₩-3.22 Billion | ₩76.36 Billion | ▼ -210.1% |
| 2022 | 0.04x | ₩2.50 Billion | ₩65.28 Billion | ▲ +52.4% |
| 2021 | 0.03x | ₩1.73 Billion | ₩68.68 Billion | ▲ +112.3% |
| 2020 | -0.21x | ₩-8.57 Billion | ₩41.78 Billion | ▼ -3145.0% |
| 2019 | 0.01x | ₩208.72 Million | ₩30.97 Billion | ▲ +132.9% |
| 2018 | -0.02x | ₩-483.80 Million | ₩23.61 Billion | ▲ +88.7% |
| 2017 | -0.18x | ₩-2.38 Billion | ₩13.07 Billion | ▲ +82.1% |
| 2016 | -1.02x | ₩-1.46 Billion | ₩1.43 Billion | — |